New plant on its Mourenx, France site to produce a large volume commercial API
Novasep, a leading provider of purification-based manufacturing solutions for life science molecules, announces today an investment of EUR 30 million to build in Europe what will be the world's largest chromatography plant used for the production of a large volume commercial API (active pharmaceutical ingredient)...
Read MoreAurox Wins 2012 QueenOct 10, 2012
Oxfordshire company receives recognition for making confocal microscopy “personal”
Aurox Limited, a leader in the design and manufacture of innovative optical imaging equipment, has won a 2012 Queen’s Award for Enterprise in Innovation. The award comes in recognition of the development and successful market introduction of the SD62 microscope, one of an ever increasing portfolio of Aurox products...
Read MoreMalvern Instruments launches Morphologi G3-ID to global marketsOct 9, 2012
Following the completion of a highly successful early access program, Malvern Instruments has launched the Morphologi G3-ID particle characterization system to the global market
A live webinar on 2 October 2012 introduced participants to the unique capabilities of the system, which combines automated particle imaging with the chemical identification of individual particles using Raman spectroscopy. This fully automated system measures particle size, shape and chemical identity in a single platform...
Read MoreThe future is bright for medical imaging companyOct 9, 2012
An advanced medical imaging company has secured £1.2m investment from two early stage technology investors
BiOxyDyn Ltd has received the investment, jointly from The North West Fund for Biomedical, managed by SPARK Impact and MTI Ventures’ UMIP Premier Fund (UPF). The North West Fund for Biomedical is a sub-fund of The North West Fund, which is jointly financed by the European Regional Development Fund and the European Investment Bank...
Read MoreThe North West Fund for Biomedical invests Oct 3, 2012
The North West Fund for Biomedical, managed by SPARK Impact, has invested £110,000 in a business that makes software that allows biomedical companies to comply with legislation
The Compliance Control Ltd software allows organisations which are subject to regulatory standards, in sectors such as pharmaceutical, life sciences and medical devices, to validate their processes and monitor their compliance in real time, replacing ad-hoc systems and unmanageable paperwork...
Read MoreMoving laser diffraction from the laboratory into the production processOct 1, 2012
In a new presentation from Malvern Instruments entitled ‘Moving laser diffraction from the laboratory into the production process’, Product Group Manager Dr. Paul Kippax discusses the benefits and challenges of taking laboratory-based particle sizing out into the production process
The presentation is particularly tailored to the pharmaceutical industry but is generally relevant to all manufacturers considering an investment in on-plant real-time particle size measurement and can be freely downloaded...
Read MoreInSphero and INTEGRA Announce CooperationSep 19, 2011
Integra Biosciences and InSphero AG, a pioneering developer of advanced 3-dimensional microtissue models, have announced today that they will cooperate on providing high performance liquid-handling solutions for 3D cell culture...
Pall Life Sciences, a global leader in filtration, separation and purification, received the 2008 Supplier of the Year Award from the European segment of VWR for its commitment to helping VWR provide quality products and services to Europe's research laboratories.